Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations

International Journal of Pharmaceutics

Volumn 402, Issue 1-2, 2010, Pages 1-9

  Donovan, Martin J ^a   Smyth, Hugh D C ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Binary formulations; Carrier particles; Dry powder inhalers; Lactose; Surface roughness

Indexed keywords

BUDESONIDE; DRUG CARRIER; LACTOSE; SUPERTAB; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; DRUG FORMULATION; DRY POWDER; FRACTIONATION; IN VITRO STUDY; MORPHOLOGY; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; SURFACE PROPERTY;

ADMINISTRATION, INHALATION; AEROSOLS; BUDESONIDE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRY POWDER INHALERS; LACTOSE; PARTICLE SIZE;

EID: 78349311366     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.08.045     Document Type: Article

References (30)

1. Begat P., Morton D.A.V., Staniforth J.N., Price R. The cohesive adhesive balance in dry powder inhaler formulations I: direct quantification by atomic force microscopy. Pharm. Res. 2004, 21:1591-1597.
2. de Boer A.H., Hagedoorn P., Gjaltema D., Goede J., Frijlink H.W. Air classifier technology (ACT) in dry powder inhalation Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. Int. J. Pharm. 2003, 260:187-200.
3. de Boer A.H., Hagedoorn P., Gjaltema D., Goede J., Frijlink H.W. Air classifier technology (ACT) in dry powder inhalation Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixture of inhalation. Int. J. Pharm. 2003, 260:201-216.
4. Cline D., Dalby R. Predicting the quality of powders for inhalation from surface energy and area. Pharm. Res. 2002, 19:1274-1277.
5. Concessio N., VanOort M.M., Knowles M.R., Hickey A.J. Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect. Pharm. Res. 1999, 16:828-834.
6. Dickhoff B.H.J., de Boer A.H., Lambregts D., Frijlink H.W. The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation as a function of carrier payload and mixing time. Eur. J. Pharm. Biopharm. 2003, 56:291-302.
7. Dickhoff B.H.J., de Boer A.H., Lambregts D., Frijlink H.W. The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation. Eur. J. Pharm. Biopharm. 2005, 59:197-205.
8. Donovan M., Smyth H.D. A new method of improving dry powder dispersion using large carrier particles. Respiratory Drug Delivery, Lisbon, Portugal 2009, 2:429-432.
9. Finlay W. The Mechanics of Inhaled Pharmaceutical Aerosols, An Introduction 2001, Academic Press, New York, NY.
10. French D.L., Edwards D.A., Niven R.W. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J. Aero. Sci. 1996, 27:769-783.
11. Hickey A.J., Mansour H.M., Telko M.J., Xu Z., Smyth H.D.C., Mulder T., McClean R., Langridge J., Papadopoulos D. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. J. Pharm. Sci. 2007, 96:1282-1301.
12. Pharmaceutical Inhalation Aerosol Technology 2004, Marcel Dekker, Inc., New York, NY. 2nd ed. A.J. Hickey (Ed.).
13. Hooton J.C., Jones M.D., Price R. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J. Pharm. Sci. 2006, 95:1288-1297.
14. Islam N., Stewart P., Larson I., Hartley P. Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?. Pharm. Res. 2004, 21:492-499.
15. Karhu M., Kuikka J., Kauppinen T., Bergstrom K., Vidgren M. Pulmonary deposition of lactose carriers used in inhalation powders. Int. J. Pharm. 2000, 196:95-103.
16. Kawashima Y., Serigano T., Hina T., Yamamoto H., Takeuchi H. Effect of surface morphology of carrier lactose on dry powder inhalation property of prankalust hydrate. Int. J. Pharm. 1998, 172:179-188.
17. Larhrib H., Zeng X.M., Martin G.P., Marriott C., Pritchard J. The use of different grades of lactose as a carrier for aerosolized salbutamol sulphate. Int. J. Pharm. 1999, 191:1-14.
18. Louey M.D., Stewart P.J. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm. Res. 2002, 19:1524-1531.
19. Louey M.D., Razia S., Stewart P.J. Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int. J. Pharm. 2003, 252:87-98.
20. Lucas P., Anderson K., Staniforth J.N. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm. Res. 1998, 15:562-569.
21. Podczeck F. The relationship between particulate properties of carrier materials and the adhesion force of drug particles in interactive mixtures. J. Adhes. Sci. Technol. 1997, 11:1089-1104.
22. Podczeck F. The relationship between physical properties of lactose monohydrate and the aerodynamic behavior of adhered drug particles. Int. J. Pharm. 1998, 160:119-130.
23. Saleem I., Smyth H., Telko M. Prediction of dry powder inhaler formulation performance from surface energetics and blending dynamics. Drug Dev. Ind. Pharm. 2008, 34:1002-1010.
24. Srichana T., Martin G.P., Marriott C. On the relationship between drug and carrier deposition from dry powder inhalers in vitro. Int. J. Pharm. 1998, 167:13-23.
25. Steckel H., Muller B.W. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int. J. Pharm. 1997, 154:31-37.
26. Steckel H., Bolzen N. Alternative sugars as potential carriers for dry powder inhalations. Int. J. Pharm. 2004, 270:297-306.
27. Tee S.K., Marriott C., Zeng X.M., Martin G.P. The use of different sugars as fine and coarse carriers for aerosolized salbutamol sulphate. Int. J. Pharm. 2000, 208:111-112.
28. Visser J. Van der Waals and other cohesive force affecting powder fluidization. Powder Technol. 1989, 58:1-10.
29. Voss A., Finlay W.H. Deagglomeration of dry powder pharmaceutical aerosols. Int. J. Pharm. 2002, 248:39-50.
30. Zeng X.M., Martin G.P., Marriott C., Pritchard J. The influence of carrier particle morphology on drug delivery by dry powder inhalers. Int. J. Pharm. 2000, 200:93-106.